The current stock price of MGCD is 11.03 null. In the past month the price increased by 0.64%. In the past year, price increased by 39.8%.
MGC Diagnostics Corporation is a medical technology company dedicated to Cardio-Respiratory health solutions. It develops, manufactures and markets non-invasive diagnostic systems. The Company serves hospitals, university-based medical centers, medical clinics, physician offices, health and fitness clubs, weight loss clinics, and personal training studios. MGC Diagnostics Corporation, formerly known as Angeion Corporation, is based in Saint Paul, Minnesota.
Mgc Diagnostics Corp.
350 OAK GROVE PARKWAY
ST PAUL MN 55127
CEO: Todd M. Austin
Phone: 651-484-4874
MGC Diagnostics Corporation is a medical technology company dedicated to Cardio-Respiratory health solutions. It develops, manufactures and markets non-invasive diagnostic systems. The Company serves hospitals, university-based medical centers, medical clinics, physician offices, health and fitness clubs, weight loss clinics, and personal training studios. MGC Diagnostics Corporation, formerly known as Angeion Corporation, is based in Saint Paul, Minnesota.
The current stock price of MGCD is 11.03 null.
MGCD does not pay a dividend.
MGCD has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
ChartMill assigns a technical rating of 10 / 10 to MGCD. When comparing the yearly performance of all stocks, MGCD is one of the better performing stocks in the market, outperforming 88.69% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to MGCD. MGCD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months MGCD reported a non-GAAP Earnings per Share(EPS) of -0.8346. The EPS decreased by -367.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -8.85% | ||
| ROA | -12.72% | ||
| ROE | -24.57% | ||
| Debt/Equity | 0 |